Clinical trial
A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent…
NCT00073541 · EMD Serono, Industry · Completed
Key facts
| NCT number | NCT00073541 |
|---|---|
| Title | A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer |
| Official title | An Open-Label Phase II Study in Subjects With Recurrent EGFR-Positive Ovarian Cancer to Investigate the Safety and Efficacy of EMD 72000 Administered as a Single Agent |
| Lead sponsor | EMD Serono, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | EMD 72000 |
| Enrollment | 38 |
| Start date | Apr 1, 2003 |
| Primary completion | Mar 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Nov 26, 2003 |
| Last update posted | Jan 20, 2017 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: